Treatment of acromegaly improves quality of life, measured by AcroQol

Clinical Endocrinology

Volumn 67, Issue 3, 2007, Pages 358-362

  Paisley, Angela N ^a   Rowles, Susannah V ^a   Roberts, Margaret E ^a   Webb, Susan M ^b   Badia, X ^c   Prieto, L ^d   Shalet, Stephen M ^a   Trainer, Peter J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Health Outcomes Research Europe   (Spain)

^d Health Outcomes Department   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; BIOCHEMISTRY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE ACTIVITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; WELLBEING;

ACROMEGALY; ADULT; AGED; COMBINED MODALITY THERAPY; DOPAMINE AGONISTS; FEMALE; HEALTH STATUS; HORMONES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 34548028472     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02891.x     Document Type: Article

References (19)

1. Rajasoorya, C., Holdaway, I.M., Wrightson, P., Scott, D.J. Ibbertson HK 1994) Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology, 41, 95 102.
2. Holdaway, I.M., Rajasoorya, C.R., Gamble, G.D. Stewart AW 2003) Long-term treatment outcome in acromegaly. Growth Hormone & IGF Research, 13, 185 192.
3. Giustina, A., Barkan, A., Casanueva, F.F., Cavagnini, F., Frohman, L., Ho, K., Veldhuis, J., Wass, J., von Werder, K. Melmed, S. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526 529.
4. Trainer, P.J., Drake, W.M., Katznelson, L. et al 2000) Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. New England Journal of Medicine, 342, 1171 1177.
5. van Der Lely, A.J., Hutson, R.K., Trainer, P.J. et al 2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet, 358, 1754 1759.
6. Rowles, S.V., Prieto, L., Badia, X. et al 2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. Journal of Clinical Endocrinology and Metabolism, 90, 3337 3341.
7. Dupuy, H. (1984) The psychological general well-being (PGWB) index. In : N.K. Wenger ed. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Le Jacq Publishing Inc., New York, 170 183.
8. Rabin, R. De Charro, F. (2001) EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33, 337 343.
9. Badia, X., Webb, S.M., Prieto, L. Lara N. (2004) Acromegaly Quality of Life Questionnaire (AcroQol). Health and Quality of Life Outcomes, 2, 13.
10. Dolan, P. (1997) Modeling valuations for EuroQol health states. Medical Care, 35, 1095 1108.
11. Madia, X. Herdman, M. Schiaffino A. (1999) Determining correspondence between scores on the EQ-5D 'thermometer' and a 5-point categorical rating scale. Medical Care, 37, 671 677.
12. Brooks, R. (1996) EuroQol: the current state of play. Health Policy, 37, 53 72.
13. Sapin, C., Fantino, B., Nowicki, M.L. Kind P. (2004) Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health and Quality of Life Outcomes, 2, 20.
14. Brabant, G., Von Zur Muhlen, A., Wuster, C. et al 2003) Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Hormone Research, 60, 53 60.
15. Sonino, N., Scarpa, E., Paoletta, A., Fallo, F. Boscaro M. (1999) Slow-release lanreotide treatment in acromegaly: effects on quality of life. Psychotherapy and Psychosomatics, 68, 165 167.
16. Bonapart, I.E., Van Domburg, R., Ten Have, S.M. et al 2005) The 'bio-assay' quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations. European Journal of Endocrinology, 152, 217 224.
17. Webb, S.M., Prieto, L., Badia, X. et al 2002) Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clinical Endocrinology, 57, 251 258.
18. Burstrom, K. Johannesson, M. Diderichsen F. (2001 Swedish population health-related quality of life results using the EQ-5D. Quality of Life Research, 10, 621 635.
19. Brazier, J.E., Harper, R., Munro, J., Walters, S.J. Snaith ML 1999) Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology, 38, 870 877.